Technical Note: Evaluation of the uncertainties in (choline + creatine)/citrate ratios measured by proton mr spectroscopic imaging in patients suspicious for prostate cancer

Š Zbýå, M. Krššák, M. Memarsadeghi, B. Gholami, A. Haitel, M. Weber, T. H. Helbich, S. Trattnig, E. Moser, S. Gruber

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The presented evaluation of the relative uncertainty (δ'CCC) of the (choline + creatine)/citrate (CC/C) ratios can provide objective information about the quality and diagnostic value of prostate MR spectroscopic imaging data. This information can be combined with the numeric values of CC/C ratios and provides metabolic-quality maps enabling accurate cancer detection and user-independent data evaluation. In addition, the prostate areas suffering most from the low precision of CC/C ratios (e. g., prostate base) were identified.

Original languageEnglish (US)
Pages (from-to)698-702
Number of pages5
JournalRoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren
Volume186
Issue number7
DOIs
StatePublished - Jul 2014
Externally publishedYes

Fingerprint Dive into the research topics of 'Technical Note: Evaluation of the uncertainties in (choline + creatine)/citrate ratios measured by proton mr spectroscopic imaging in patients suspicious for prostate cancer'. Together they form a unique fingerprint.

  • Cite this